THAR: SEC Form DEF 14A filed by Tharimmune Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for THAR
Across the 5 sessions after earlier THAR headlines, the stock closed higher 2 times and lower 3 times, with a median move of 5.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | THAR | SPY |
|---|---|---|---|
| Dec 18, 2025 | Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network | -5.9% | +0.8% |
| Dec 12, 2025 | Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy | -5.5% | -1.1% |
| Nov 13, 2025 | Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids | -6.5% | -1.7% |
| Nov 7, 2025 | Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy | +1.0% | +0.1% |
| Nov 3, 2025 | Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy | +8.5% | +0.2% |
Quantisnow market dataNASDAQ
THAR
Tharimmune Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2022
Get push alerts for THAR
Full THAR profile on Quantisnow Follow THAR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time